Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
帕金森病患者接受联合代谢激活剂治疗后认知功能改善的多组学表征：一项随机、双盲、安慰剂对照的II期试验
期刊:Brain Communications
影响因子:4.5
doi:10.1093/braincomms/fcae478
Yulug, Burak; Altay, Ozlem; Li, Xiangyu; Hanoglu, Lutfu; Cankaya, Seyda; Velioglu, Halil A; Lam, Simon; Yang, Hong; Coskun, Ebru; Idil, Ezgi; Bayraktaroglu, Zubeyir; Nogaylar, Rahim; Ozsimsek, Ahmet; Yildirim, Serkan; Bolat, Ismail; Kiliclioglu, Metin; Bayram, Cemil; Yuksel, Nursena; Tozlu, Ozlem O; Arif, Muhammad; Shoaie, Saeed; Hacimuftuoglu, Ahmet; Zhang, Cheng; Nielsen, Jens; Turkez, Hasan; Borén, Jan; Uhlén, Mathias; Mardinoglu, Adil
